| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-07 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-06 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-06 |